Avidity Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Avidity Biosciences Stock Summary

Avidity Biosciences competes with Cullinan Oncology, Aerovate Therapeutics, Structure Therapeutics, Lyra Therapeutics, and Gossamer Bio. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California. Avidity Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 125 people.

Avidity Biosciences Key Financial Ratios

Avidity Biosciences Key Balance Sheet Accounts

Avidity Biosciences Key Income Statement Accounts

Avidity Biosciences Key Cash Accounts

Avidity Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Avidity Biosciences's current stock value. Our valuation model uses many indicators to compare Avidity Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avidity Biosciences competition to find correlations between indicators driving Avidity Biosciences's intrinsic value. More Info.Avidity Biosciences is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . At present, Avidity Biosciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avidity Biosciences' earnings, one of the primary drivers of an investment's value.

Avidity Biosciences Systematic Risk

Today, most investors in Avidity Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Avidity Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Avidity Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Avidity Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Avidity Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Avidity Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Avidity Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Avidity Biosciences's daily price indicators and compare them against related drivers.

When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.